Gastrointestinal Stromal Tumor
Gastrointestinal stromal tumors (GISTs) are rare tumors that arise in the digestive tract, often in the stomach or intestines, and can cause symptoms like abdominal pain, nausea, and gastrointestinal bleeding.
Gastrointestinal Stromal Tumor: Adjuvant Imatinib Study
We are studying whether adjuvant Imatinib can help prevent cancer recurrence in patients with intermediate-risk gastrointestinal stromal tumors. This trial compares its effects on survival and quality of life against standard treatments.
What diseases are being studied?
Health conditions and diseases that the clinical trial is designed to study and treat.
Who can participate in the clinical trial?
These questions help us understand your situation so we can let the trial team know whether you might be a potential match. This is not a medical evaluation and is not part of the official screening, the study doctor will make the final decision..
- Are you 18 years old or older?
- Have you had any chemotherapy, radiation therapy, or targeted therapy in the past 3 years?
- Do you have a gastrointestinal stromal tumor that is classified as intermediate risk?
- Have you had surgery for your primary tumor within the last 2 to 3 months?
- Do you have any evidence of distant metastases (cancer spread to other parts of the body)?
What similar medicines might you know?
Don't worry if you don't know the medicines tested in the trial. There is a chance you have heard about the similar medicines. Check the list below to see if you are familiar with any of them.
Bimatix
Glipox
Glivec
Where is the clinical trial being conducted?
Locations and medical facilities where this clinical trial is currently recruiting or conducting research. Select the locations where you would like to participate.
Loading map...
CHU Besancon
oncologie medciale
Besançon, France
Institut Bergonie
oncologie médicale
Bordeaux, France
Centre Hospitalier Universitaire Reims
Servive de Gastro-entérologie et Cancérologie Digestive
Cormontreuil, France
Sponsor: Centre Hospitalier Regional De Marseille
Last updated: Nov 27, 2025
Disclaimer: Parts of this content have been automatically extracted from the EU Clinical Trials registry. While we strive for accuracy, please always contact the trial site or sponsor directly for correct and official information before making any decisions about participation. View on EU Clinical Trials.